Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (131-140 of 311) with videos related to

Pageof 32
Sort By:
Cells|April 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of MelanomaAhmad Najem, Laura Soumoy, Malak Sabbah, et al.
Critical Reviews in Oncology/Hematology|April 8, 2006
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm)Gilberto de Castro Junior, Fabio Puglisi, Evandro de Azambuja, et al.
Surgical Oncology|November 6, 2020
Diagnosis, pathophysiology, and treatment of SIRT-induced gastroduodenal ulcers: A systematic literature reviewBelcaid Laila, Ledouble Vinciane, Vouche Michael, et al.
Breast Cancer Research and Treatment|November 9, 2014
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studiesChris Twelves, Javier Cortes, Linda Vahdat, et al.
Molecular and Clinical Oncology|June 11, 2016
Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancerSpyridon Sideris, Fouad Aoun, Marc Zanaty, et al.
Oncotarget|June 3, 2024
Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaMohammad Krayem, Ahmad Najem, Fabrice Journe, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2023
Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumoursPatrick Schöffski, Jean-Pascal Machiels, Sylvie Rottey, et al.
Critical Reviews in Oncology/Hematology|February 19, 2011
Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectivesNagi S El Saghir, Arafat Tfayli, Hassan A Hatoum, et al.
JCO Precision Oncology|January 21, 2026
Innovative Research Organization to Facilitate Clinical Trials Implementation in the Era of Molecular Oncology: The Spiderweb Model of the Oncodistinct NetworkSimon Nannini, Anthony Goncalves, Carlos Gomez-Roca, et al.
Breast (Edinburgh, Scotland)|April 2, 2021
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experienceMaria Alice Franzoi, Rita Saúde-Conde, Sofia Cristóvão Ferreira, et al.
Pageof 32

Showing results (131-140 of 311) with videos related to

Sort By:
Pageof 32
Cells|April 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of MelanomaAhmad Najem, Laura Soumoy, Malak Sabbah, et al.
Critical Reviews in Oncology/Hematology|April 8, 2006
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm)Gilberto de Castro Junior, Fabio Puglisi, Evandro de Azambuja, et al.
Surgical Oncology|November 6, 2020
Diagnosis, pathophysiology, and treatment of SIRT-induced gastroduodenal ulcers: A systematic literature reviewBelcaid Laila, Ledouble Vinciane, Vouche Michael, et al.
Breast Cancer Research and Treatment|November 9, 2014
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studiesChris Twelves, Javier Cortes, Linda Vahdat, et al.
Molecular and Clinical Oncology|June 11, 2016
Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancerSpyridon Sideris, Fouad Aoun, Marc Zanaty, et al.
Oncotarget|June 3, 2024
Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaMohammad Krayem, Ahmad Najem, Fabrice Journe, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2023
Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumoursPatrick Schöffski, Jean-Pascal Machiels, Sylvie Rottey, et al.
Critical Reviews in Oncology/Hematology|February 19, 2011
Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectivesNagi S El Saghir, Arafat Tfayli, Hassan A Hatoum, et al.
JCO Precision Oncology|January 21, 2026
Innovative Research Organization to Facilitate Clinical Trials Implementation in the Era of Molecular Oncology: The Spiderweb Model of the Oncodistinct NetworkSimon Nannini, Anthony Goncalves, Carlos Gomez-Roca, et al.
Breast (Edinburgh, Scotland)|April 2, 2021
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experienceMaria Alice Franzoi, Rita Saúde-Conde, Sofia Cristóvão Ferreira, et al.
Pageof 32